Red Blood Cell Surface Tagging via Click Chemistry
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for in vivo surface engineering of red blood cells (RBCs) are limited by poor specificity, low efficiency, and potential toxicity, making it difficult to covalently conjugate cargos effectively.
Innovation Solution
Utilizing click chemistry, specifically azide-alkyne, tetrazine-norbornene, tetrazine-cyclooctene, or maleimide-thiol click chemistry, to covalently link proteins or lipids to the surface of RBCs, enabling efficient conjugation of cargos such as autoantigens, drugs, or imaging agents.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Stability of the object's composition
If covalent conjugation methods are used to attach cargos to RBCs, then the stability and durability of cargo attachment is improved, but the toxicity and functional impairment of RBCs increases
Solution Approach 1:
The invention changes the chemical parameters of the conjugation reaction by using copper-free click chemistry (strain-promoted azide-alkyne cycloaddition) instead of traditional copper-catalyzed click chemistry or other covalent methods. This parameter change eliminates copper toxicity while maintaining covalent bond stability, resolving the contradiction between attachment stability and RBC toxicity
Solution Approach 2:
The invention introduces azide-modified sugars as metabolic intermediaries that are incorporated into RBC surface glycoproteins and glycolipids. These intermediaries serve as safe attachment points for cargo molecules through bioorthogonal chemistry, avoiding direct toxic chemical modification of RBC membranes while achieving stable cargo conjugation
2Reliability
If in vivo surface engineering of RBCs is performed, then the therapeutic efficacy and tissue accumulation are improved, but the specificity and efficiency of cargo conjugation deteriorates
Solution Approach 1:
The invention performs preliminary metabolic labeling of RBCs with azide-modified sugars in vivo before cargo administration. This preliminary action creates pre-formed attachment sites on RBC surfaces, enabling efficient and specific cargo conjugation to occur subsequently without requiring complex in vivo chemical reaction conditions
Solution Approach 2:
The invention extracts the cargo conjugation process from the complex in vivo environment by using metabolically incorporated azide tags that remain on RBC surfaces. This allows cargo attachment to be decoupled from challenging in vivo conditions, enabling efficient conjugation while maintaining the therapeutic benefits of in vivo engineering
3Quantity of substance
If traditional covalent conjugation methods are used, then the cargo attachment is achieved, but the RBC survival and functional performance deteriorates
Solution Approach 1:
The invention changes the chemical parameters of conjugation from traditional methods (amine-reactive, thiol-reactive, or copper-catalyzed click chemistry) to copper-free strain-promoted click chemistry. This parameter change enables cargo attachment without copper toxicity that would otherwise damage RBCs and reduce their lifespan, maintaining both attachment quantity and RBC survival
Solution Approach 2:
The invention converts the metabolic activity of RBCs, which normally leads to their clearance, into a benefit by using their glycosylation machinery to incorporate azide-modified sugars into surface molecules. This metabolic incorporation creates stable cargo attachment sites while the RBCs maintain their natural long circulation lifespan
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
This approach allows for safe and efficient conjugation of cargos to RBCs, enhancing their therapeutic efficacy, tissue accumulation, and imaging capabilities without significant toxicity or functional impairment.
Implementation Method 1
Utilizing click chemistry, specifically azide-alkyne, tetrazine-norbornene, tetrazine-cyclooctene, or maleimide-thiol click chemistry, to covalently link proteins or lipids to the surface of RBCs
Data Source
AI summary
Modified red blood cells (RBCs) including one or more surface proteins or lipids covalently linked to a cargo by click chemistry are provided. In some examples, the cargo is a cancer therapeutic agent, an autoimmune antigen, or an antigen of a bacterial or viral agent. Also provided are methods of treating a subject with a disease or disorder with the modified RBCs or methods of treating a subject with a disease or disorder or performing imaging analysis of a subject, including administering to the subject a composition including an azido-modified sugar moiety, thereby generating red blood cells comprising one or more azido-labeled surface proteins and administering to the subject a composition including a cargo for treating or inhibiting the disease or disorder, wherein the cargo is capable of covalently binding to the one or more azido-labeled surface proteins or lipids.